Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Erythema nodosum (looking for a cause)

Dermatology · Symptom or situation · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: Annual incidence of 52 cases per million inhabitants aged 14 and over (biopsy-proven erythema nodosum, north-west Spain); five women for one man in adults [1]

Initial tests

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (7)
  1. Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, Gomez-Flores M. Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021;22(3):367-378.
  2. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 4103 (IGRA), 1323-1324 (anti-enzymes streptococciques), 5209 (sphère ORL) ; absence d'acte pour la VS.
  3. Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician. 2007;75(5):695-700.
  4. DermNet (Nouvelle-Zélande). Erythema nodosum. Article original de 1997, mis à jour par A. Akbari ; rédactrice en chef A. Oakley, dermatologue, octobre 2019.
  5. Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol. 1998;37(9):667-72.
  6. Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R. Erythema nodosum: an experience of 10 years. Scand J Infect Dis. 2004;36(6-7):424-7.
  7. British Association of Dermatologists. Erythema nodosum. Patient information leaflet, mai 2017, révisée en avril 2021.